JP2004509617A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004509617A5 JP2004509617A5 JP2002525188A JP2002525188A JP2004509617A5 JP 2004509617 A5 JP2004509617 A5 JP 2004509617A5 JP 2002525188 A JP2002525188 A JP 2002525188A JP 2002525188 A JP2002525188 A JP 2002525188A JP 2004509617 A5 JP2004509617 A5 JP 2004509617A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- nucleic acid
- seq
- cells
- kit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 229920001184 polypeptide Polymers 0.000 description 28
- 108090000765 processed proteins & peptides Proteins 0.000 description 28
- 102000004196 processed proteins & peptides Human genes 0.000 description 28
- 108020004707 nucleic acids Proteins 0.000 description 22
- 102000039446 nucleic acids Human genes 0.000 description 22
- 150000007523 nucleic acids Chemical class 0.000 description 22
- 210000004027 cell Anatomy 0.000 description 14
- 150000001875 compounds Chemical class 0.000 description 13
- 150000001413 amino acids Chemical class 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 8
- 241000288906 Primates Species 0.000 description 5
- 239000000427 antigen Substances 0.000 description 5
- 108091007433 antigens Proteins 0.000 description 5
- 102000036639 antigens Human genes 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000002773 nucleotide Substances 0.000 description 5
- 125000003729 nucleotide group Chemical group 0.000 description 5
- 239000003814 drug Substances 0.000 description 4
- 230000000890 antigenic effect Effects 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 238000009396 hybridization Methods 0.000 description 3
- 230000035479 physiological effects, processes and functions Effects 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 230000003053 immunization Effects 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 238000007911 parenteral administration Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000011200 topical administration Methods 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 102000002029 Claudin Human genes 0.000 description 1
- 108050009302 Claudin Proteins 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 231100000219 mutagenic Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 238000002823 phage display Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
Images
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23126700P | 2000-09-08 | 2000-09-08 | |
| PCT/US2001/028013 WO2002020569A2 (en) | 2000-09-08 | 2001-09-07 | Mammalian genes; related reagents and methods |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008218815A Division JP2009039124A (ja) | 2000-09-08 | 2008-08-27 | 哺乳動物遺伝子；関連試薬および方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004509617A JP2004509617A (ja) | 2004-04-02 |
| JP2004509617A5 true JP2004509617A5 (https=) | 2008-10-16 |
Family
ID=22868480
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002525188A Withdrawn JP2004509617A (ja) | 2000-09-08 | 2001-09-07 | 哺乳動物遺伝子；関連試薬および方法 |
| JP2008218815A Withdrawn JP2009039124A (ja) | 2000-09-08 | 2008-08-27 | 哺乳動物遺伝子；関連試薬および方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008218815A Withdrawn JP2009039124A (ja) | 2000-09-08 | 2008-08-27 | 哺乳動物遺伝子；関連試薬および方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (6) | US7060800B2 (https=) |
| EP (2) | EP1315743B1 (https=) |
| JP (2) | JP2004509617A (https=) |
| CN (1) | CN1452633A (https=) |
| AT (1) | ATE549347T1 (https=) |
| AU (1) | AU2001294541A1 (https=) |
| CA (1) | CA2419979A1 (https=) |
| MX (1) | MXPA03002049A (https=) |
| WO (1) | WO2002020569A2 (https=) |
Families Citing this family (58)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001034769A2 (en) * | 1999-11-05 | 2001-05-17 | Human Genome Sciences, Inc. | 24 human secreted proteins |
| AU2253301A (en) | 1999-12-03 | 2001-06-12 | Zymogenetics Inc. | Human cytokine receptor |
| US20030170823A1 (en) | 1999-12-23 | 2003-09-11 | Presnell Scott R. | Novel cytokine ZCYTO18 |
| DE60123998T2 (de) | 2000-08-08 | 2007-09-06 | Zymogenetics, Inc., Seattle | Lösliche zcyctor 11 cytokinrezeptoren |
| US7358353B2 (en) | 2000-08-22 | 2008-04-15 | Agensys, Inc. | Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers |
| EP1311675B1 (en) * | 2000-08-22 | 2007-02-07 | Agensys, Inc. | Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers |
| ATE549347T1 (de) * | 2000-09-08 | 2012-03-15 | Schering Corp | Gene von säugetiere, und damit verbundene reagentien, methoden |
| US20020151695A1 (en) * | 2000-11-28 | 2002-10-17 | Shuqian Jing | Transforming growth factor-beta-related molecules and uses thereof |
| JP2004532611A (ja) * | 2000-11-28 | 2004-10-28 | ザイモジェネティクス，インコーポレイティド | サイトカイン受容体ｚｃｙｔｏｒ１９ |
| CA2439961A1 (en) | 2001-03-27 | 2002-10-03 | Zymogenetics, Inc. | Human cytokine receptor |
| US7910313B2 (en) | 2001-04-20 | 2011-03-22 | Zymogenetics, Inc. | Cytokine protein family |
| US7038032B2 (en) | 2001-04-20 | 2006-05-02 | Zymogenetics, Inc. | Cytokine protein family |
| CA2462687A1 (en) * | 2001-10-02 | 2003-04-17 | Mochida Pharmaceutical Co., Ltd. | Novel class ii cytokine receptor |
| US7033787B2 (en) * | 2001-12-21 | 2006-04-25 | Ludwig Institute For Cancer Research | Isolated cytokine receptor LICR-2 |
| AU2003223344B9 (en) | 2002-03-22 | 2009-07-16 | Zymogenetics, Inc. | Anti-IL-TIF antibodies and methods of using in inflammation |
| CN1659274A (zh) * | 2002-04-19 | 2005-08-24 | 津莫吉尼蒂克斯公司 | 细胞因子受体 |
| US7141381B2 (en) | 2002-04-25 | 2006-11-28 | Bristol-Myers Squibb Company | Human leucine-rich repeat-containing proteins specifically expressed in the nervous system |
| ES2348230T3 (es) | 2002-06-07 | 2010-12-01 | Dyax Corp. | Prevención y reducción de la isquemia. |
| CA2503305A1 (en) | 2002-10-23 | 2004-05-06 | Zymogenetics, Inc. | Methods for treating viral infection using il-28 and il-29 |
| DE10254601A1 (de) | 2002-11-22 | 2004-06-03 | Ganymed Pharmaceuticals Ag | Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung |
| JP2007524361A (ja) * | 2003-02-10 | 2007-08-30 | アジェンシス， インコーポレイテッド | 膀胱癌及びその他の癌の治療及び検出に有用な名称１５８ｐ１ｄ７の核酸及び対応タンパク質 |
| JP2007525438A (ja) | 2003-03-24 | 2007-09-06 | ザイモジェネティクス， インコーポレイテッド | 抗ｉｌ−２２ｒａ抗体および結合パートナー、ならびに炎症における使用法 |
| EP2251352A1 (en) | 2003-08-07 | 2010-11-17 | ZymoGenetics, L.L.C. | Homogeneous preparations of IL-28 and IL-29 |
| US20050089515A1 (en) * | 2003-08-29 | 2005-04-28 | Dyax Corp. | Poly-pegylated protease inhibitors |
| GB0325038D0 (en) * | 2003-10-27 | 2003-12-03 | Ares Trading Sa | Protein |
| JP4896005B2 (ja) | 2004-04-02 | 2012-03-14 | ザイモジェネティクス リミテッド ライアビリティ カンパニー | Ｉｌ−２８およびｉｌ−２９システイン変異体を用いるウイルス感染を治療するための方法 |
| DE102004024617A1 (de) | 2004-05-18 | 2005-12-29 | Ganymed Pharmaceuticals Ag | Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung |
| JP2008508310A (ja) | 2004-07-29 | 2008-03-21 | ザイモジェネティクス， インコーポレイテッド | がんおよび自己免疫障害を治療するためのｉｌ−２８およびｉｌ−２９の使用法 |
| US7235530B2 (en) | 2004-09-27 | 2007-06-26 | Dyax Corporation | Kallikrein inhibitors and anti-thrombolytic agents and uses thereof |
| AU2005299809B2 (en) | 2004-10-22 | 2010-12-02 | Zymogenetics, Inc. | Anti-IL-22RA antibodies and binding partners and methods of using in inflammation |
| GB0423973D0 (en) * | 2004-10-28 | 2004-12-01 | Ares Trading Sa | C1q related points |
| JP2008539194A (ja) * | 2005-04-26 | 2008-11-13 | ラボラトワール セローノ ソシエテ アノニム | 癌および／または関節炎の新たな治療および／または予防 |
| AU2006272937A1 (en) | 2005-07-20 | 2007-02-01 | Bristol-Myers Squibb Company | Use of truncated cysteine IL28 and IL29 mutants to treat cancers and autoimmune disorders |
| EP1790664A1 (en) | 2005-11-24 | 2007-05-30 | Ganymed Pharmaceuticals AG | Monoclonal antibodies against claudin-18 for treatment of cancer |
| US20090182035A1 (en) * | 2007-04-11 | 2009-07-16 | Alcon Research, Ltd. | Use of a combination of olopatadine and cilomilast to treat non-infectious rhinitis and allergic conjunctivitis |
| KR20100014565A (ko) * | 2007-04-11 | 2010-02-10 | 알콘 리서치, 리미티드 | 알레르기성 비염 및 알레르기성 결막염을 치료하기 위한 ｔｎｆａ의 억제제 및 항히스타민의 용도 |
| EP2915564B1 (en) | 2007-09-28 | 2020-11-04 | Portola Pharmaceuticals, Inc. | Antidotes for factor XA inhibitors and methods of using the same |
| EP3121271B1 (en) | 2009-03-30 | 2019-07-24 | Portola Pharmaceuticals, Inc. | Antidotes for factor xa inhibitors and methods of using the same |
| ES2605801T3 (es) | 2009-07-15 | 2017-03-16 | Portola Pharmaceuticals, Inc. | Formulación de dosis unitaria de antídoto para inhibidores del factor Xa para su uso en la prevención de la hemorragia |
| CN102548536A (zh) * | 2009-10-01 | 2012-07-04 | 爱尔康研究有限公司 | 奥洛他定组合物及其用途 |
| WO2013016449A2 (en) | 2011-07-26 | 2013-01-31 | Indicator Systems International, Inc. | Assays for the detection of microbes |
| CA2867444C (en) | 2012-03-16 | 2021-04-13 | University Health Network | Compositions containing soluble toso protein and uses thereof |
| WO2013167153A1 (en) | 2012-05-09 | 2013-11-14 | Ganymed Pharmaceuticals Ag | Antibodies useful in cancer diagnosis |
| WO2013174404A1 (en) | 2012-05-23 | 2013-11-28 | Ganymed Pharmaceuticals Ag | Combination therapy involving antibodies against claudin 18.2 for treatment of cancer |
| TWI606063B (zh) | 2012-08-23 | 2017-11-21 | 艾澤西公司 | 結合至１５８ｐ１ｄ７蛋白之抗體藥物結合物（ａｄｃ） |
| JP6499079B2 (ja) | 2012-11-13 | 2019-04-10 | バイオエヌテック アーゲーＢｉｏＮＴｅｃｈ ＡＧ | クローディンを発現するガン疾患を処置するための剤 |
| WO2014127785A1 (en) | 2013-02-20 | 2014-08-28 | Ganymed Pharmaceuticals Ag | Combination therapy involving antibodies against claudin 18.2 for treatment of cancer |
| WO2014146672A1 (en) | 2013-03-18 | 2014-09-25 | Ganymed Pharmaceuticals Ag | Therapy involving antibodies against claudin 18.2 for treatment of cancer |
| AU2015225867B2 (en) | 2014-03-07 | 2020-02-06 | University Health Network | Methods and compositions for modifying the immune response |
| US10428158B2 (en) | 2014-03-27 | 2019-10-01 | Dyax Corp. | Compositions and methods for treatment of diabetic macular edema |
| US10287338B2 (en) | 2015-07-10 | 2019-05-14 | Miran NERSISSIAN | Factor VIII protein compositions and methods of treating of hemophilia A |
| WO2017023863A1 (en) | 2015-07-31 | 2017-02-09 | Research Institute At Nationwide Children's Hospital | Peptides and antibodies for the removal of biofilms |
| EP3365027B1 (en) | 2015-10-14 | 2022-03-30 | Research Institute at Nationwide Children's Hospital | Hu specific antibodies and their use in inhibiting biofilm |
| US11564982B2 (en) | 2017-01-04 | 2023-01-31 | Research Institute At Nationwide Children's Hospital | DNABII vaccines and antibodies with enhanced activity |
| JP7661008B2 (ja) | 2017-01-04 | 2025-04-14 | リサーチ インスティチュート アット ネイションワイド チルドレンズ ホスピタル | バイオフィルム関連障害の処置のための抗体断片 |
| WO2018170178A1 (en) | 2017-03-15 | 2018-09-20 | Research Institute At Nationwide Children's Hospital | Composition and methods for disruption of bacterial biofilms without accompanying inflammation |
| CN110229226B (zh) * | 2019-05-23 | 2023-04-11 | 西安医学院 | 一种slfn11截断肽及其应用和药物组合物 |
| AU2020311897A1 (en) | 2019-07-08 | 2022-02-03 | Research Institute At Nationwide Children's Hospital | Antibody compositions for disrupting biofilms |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US88426A (en) | 1869-03-30 | Improved velocipede | ||
| US2736896A (en) | 1951-12-04 | 1956-02-28 | Sperry Rand Corp | Horn antenna system |
| FR2046920B1 (https=) | 1969-06-19 | 1974-05-03 | Citizen Watch Co Ltd | |
| US3940475A (en) | 1970-06-11 | 1976-02-24 | Biological Developments, Inc. | Radioimmune method of assaying quantitatively for a hapten |
| NL154598B (nl) | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
| US3817837A (en) | 1971-05-14 | 1974-06-18 | Syva Corp | Enzyme amplification assay |
| US3939350A (en) | 1974-04-29 | 1976-02-17 | Board Of Trustees Of The Leland Stanford Junior University | Fluorescent immunoassay employing total reflection for activation |
| US3996345A (en) | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
| US4277437A (en) | 1978-04-05 | 1981-07-07 | Syva Company | Kit for carrying out chemically induced fluorescence immunoassay |
| US4275149A (en) | 1978-11-24 | 1981-06-23 | Syva Company | Macromolecular environment control in specific receptor assays |
| US4366241A (en) | 1980-08-07 | 1982-12-28 | Syva Company | Concentrating zone method in heterogeneous immunoassays |
| US4659678A (en) | 1982-09-29 | 1987-04-21 | Serono Diagnostics Limited | Immunoassay of antigens |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4859609A (en) | 1986-04-30 | 1989-08-22 | Genentech, Inc. | Novel receptors for efficient determination of ligands and their antagonists or agonists |
| US6277969B1 (en) * | 1991-03-18 | 2001-08-21 | New York University | Anti-TNF antibodies and peptides of human tumor necrosis factor |
| US6270989B1 (en) | 1991-11-05 | 2001-08-07 | Transkaryotic Therapies, Inc. | Protein production and delivery |
| ATE549347T1 (de) * | 2000-09-08 | 2012-03-15 | Schering Corp | Gene von säugetiere, und damit verbundene reagentien, methoden |
| US11068393B2 (en) | 2019-10-17 | 2021-07-20 | Microsoft Technology Licensing, Llc | Enhanced concurrency garbage collection stack scanning |
-
2001
- 2001-09-07 AT AT10179792T patent/ATE549347T1/de active
- 2001-09-07 CN CN01815161A patent/CN1452633A/zh active Pending
- 2001-09-07 US US09/949,192 patent/US7060800B2/en not_active Expired - Fee Related
- 2001-09-07 EP EP01975188A patent/EP1315743B1/en not_active Expired - Lifetime
- 2001-09-07 JP JP2002525188A patent/JP2004509617A/ja not_active Withdrawn
- 2001-09-07 AU AU2001294541A patent/AU2001294541A1/en not_active Abandoned
- 2001-09-07 MX MXPA03002049A patent/MXPA03002049A/es unknown
- 2001-09-07 WO PCT/US2001/028013 patent/WO2002020569A2/en not_active Ceased
- 2001-09-07 EP EP10179792A patent/EP2298789B1/en not_active Expired - Lifetime
- 2001-09-07 CA CA002419979A patent/CA2419979A1/en not_active Abandoned
-
2005
- 2005-03-25 US US11/090,448 patent/US7427668B2/en not_active Expired - Fee Related
-
2008
- 2008-08-27 JP JP2008218815A patent/JP2009039124A/ja not_active Withdrawn
- 2008-09-22 US US12/235,404 patent/US7696317B2/en not_active Expired - Fee Related
-
2009
- 2009-12-22 US US12/644,404 patent/US7893211B2/en not_active Expired - Fee Related
-
2010
- 2010-12-21 US US12/974,559 patent/US8148507B2/en not_active Expired - Fee Related
-
2012
- 2012-03-07 US US13/414,496 patent/US8426573B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004509617A5 (https=) | ||
| JP4089920B2 (ja) | 細菌レセプター構造体 | |
| US20040018587A1 (en) | Nanostructures containing antibody assembly units | |
| EP1485128A2 (en) | Nanostructures containing antibody assembly units | |
| JPH02295487A (ja) | キメラモノクローナル抗体の産生のための発現系 | |
| JP2003500010A5 (https=) | ||
| JPH05509234A (ja) | ヒトＴリンパ球レセプターのα鎖の可変領域をコードするヌクレオチド配列対応するペプチドセグメント並びに診断及び治療への利用 | |
| JP3570737B2 (ja) | リステリア検出のための方法および試薬 | |
| CN115976076A (zh) | HBC-SpyTag003融合基因、其表达载体、单克隆抗体及其应用 | |
| JPH08242865A (ja) | ヒト免疫グロブリンｅ結合因子活性ポリペプチドをコードする遺伝子系 | |
| CA2125486C (en) | Platelet gpiiia p1 a1 and p1 a2 epitopes, their preparation and use | |
| JPH09507745A (ja) | 組換えＰｉｌＣタンパク質、それらの製造方法及び使用方法 | |
| CN101368173B (zh) | 抗人cd44的工程抗体、载体、试剂盒及其用途 | |
| CN107759692A (zh) | 一种抗ca125的纳米抗体 | |
| JPS5944399A (ja) | 新規ｄｎａ | |
| CN113214364A (zh) | 一种多重耐药鲍曼不动杆菌识别元件的挖掘与验证 | |
| JP2009542243A5 (https=) | ||
| JP4521519B2 (ja) | 部分ヒストンテイル型イムノポーター | |
| JPH05509233A (ja) | 結核菌蛋白ｍｔｐ４０のヌクレオチドおよびアミノ酸配列並びにそれに由来する合成ペプチド | |
| CN119978135B (zh) | Sumo标签蛋白的特异性抗体及其制备方法与应用 | |
| CN114349859B (zh) | 抗EGFRvⅢ的纳米抗体EGFRvⅢ/Nb1-11及其制备方法与应用 | |
| CN113201069A (zh) | mcherry或mEOS纳米抗体及其制备方法和应用 | |
| CN106928359B (zh) | 一种CD105纳米抗体Nb59 | |
| CN120795135B (zh) | 一种甲流病毒n蛋白单克隆抗体27h4及其制备方法和应用 | |
| JPH11124398A (ja) | Ｃ型肝炎ウイルス由来の抗原ペプチドとそれを用いる抗体検査薬 |